Treatment duration for uncomplicated staphylococcus aureus bacteremia to prevent relapse: Analysis of a prospective observational cohort study

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1150-1156

  Chong, Yong Pil ^a   Moon, Song Mi ^a   Bang, Kyung Mi ^a   Park, Hyun Jung ^a   Park, So Youn ^a   Kim, Mi Na ^a   Park, Ki Ho ^a   Kim, Sung Han ^a   Lee, Sang Oh ^a   Choi, Sang Ho ^a   Jeong, Jin Yong ^a   Woo, Jun Hee ^a   Kim, Yang Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; LINEZOLID; NAFCILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CATHETER INFECTION; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; STAPHYLOCOCCAL BACTEREMIA; TERTIARY HEALTH CARE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; BACTEREMIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT FAILURE;

EID: 84874082494     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01021-12     Document Type: Article

References (42)

1. Wilson R, Hamburger M. 1957. Fifteen years' experience with staphylococcus septicemia in a large city hospital; analysis of fifty-five cases in the Cincinnati General Hospital 1940 to 1954. Am. J. Med. 22:437- 457.
2. Espersen F, Frimodt-Møller N. 1986. Staphylococcus aureus endocarditis. A review of 119 cases. Arch. Intern. Med. 146:1118 -1121.
3. Iannini PB, Crossley K. 1976. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann. Intern. Med. 84:558 -560.
4. Raad II, Sabbagh MF. 1992. Optimal duration of therapy for catheterrelated Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin. Infect. Dis. 14:75- 82.
5. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. 1995. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch. Intern. Med. 155:1161-1166.
6. Zeylemaker MM, Jaspers CA, van Kraaij MG, Visser MR, Hoepelman IM. 2001. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 20:380 -384.
7. Pigrau C, Rodriguez D, Planes AM, Almirante B, Larrosa N, Ribera E, Gavalda J, Pahissa A. 2003. Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary? Eur. J. Clin. Microbiol. Infect. Dis. 22:713-719.
8. Jernigan JA, Farr BM. 1993. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann. Intern. Med. 119: 304-311.
9. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. 2003. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322-332.
10. Fowler VG, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ. 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163:2066- 2072.
11. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak JM, Talan DA, Chambers HF. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52: e18-e55.
12. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fatkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653- 665.
13. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. 2008. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46:1000 -1008.
14. Chow J, Fine M, Shlaes D, Quinn J, Hooper D, Johnson M, Ramphal R, Wagener M, Miyashiro D, Yu V. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
15. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. 2001. Guidelines for the management of intravascular catheter- related infections. Clin. Infect. Dis. 32:1249 -1272.
16. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1- 45.
17. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30:633- 638.
18. Friedman N, Kaye K, Stout J, McGarry S, Trivette S, Briggs J, Lamm W, Clark C, MacFarquhar J, Walton A, Reller L, Sexton D. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797.
19. Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. 2003. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333-339.
20. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. 2003. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
21. Kaasch AJ, Fowler VG, Rieg S, Peyerl-Hoffmann G, Birkholz H, Hell-mich M, Kern WV, Seifert H. 2011. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin. Infect. Dis. 53:1-9.
22. Fowler VG Jr, Justice A, Moore C, Benjamin DK Jr, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ. 2005. Risk factors for hematogenous complications of intravascular catheterassociated Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40:695-703.
23. Fowler VG, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T. 1997. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J. Am. Coll. Cardiol. 30:1072-1078.
24. Nolan CM, Beaty HN. 1976. Staphylococcus aureus bacteremia. Current clinical patterns. Am. J. Med. 60:495-500.
25. Blyth CC, Darragh H, Whelan A, O'Shea JP, Beaman MH, McCarthy JS. 2002. Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia. Intern. Med. J. 32:224 -232.
26. Johnson LB, Almoujahed MO, Ilg K, Maolood L, Khatib R. 2003. Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse. Scand. J. Infect. Dis. 35:782- 789.
27. Thomas MG, Morris AJ. 2005. Cannula-associated Staphylococcus aureus bacteraemia: outcome in relation to treatment. Intern. Med. J. 35:319- 330.
28. Kreisel K, Boyd K, Langenberg P, Roghmann MC. 2006. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn. Microbiol. Infect. Dis. 55:179 -184.
29. Walker TM, Bowler IC, Bejon P. 2009. Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study. J. Infect. 58:411- 416.
30. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, Torok ME, Walker S, Wertheim HF, Wilson P, Llewelyn MJ. 2011. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect. Dis. 11:208 -222.
31. Rosen AB, Fowler VG, Corey GR, Downs SM, Biddle AK, Li J, Jollis JG. 1999. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann. Intern. Med. 130:810-820.
32. Sullenberger AL, Avedissian LS, Kent SM. 2005. Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J. Heart Valve Dis. 14:23-28.
33. Naber CK, Baddour LM, Giamarellos-Bourboulis EJ, Gould IM, Herrmann M, Hoen B, Karchmer AW, Kobayashi Y, Kozlov RS, Lew D, Miró JM, Moellering RC, Philippe M, Peters G, Rubinstein E, Seifert H, Corey GR. 2009. Clinical Consensus Conference: survey on Grampositive bloodstream infections with a focus on Staphylococcus aureus. Clin. Infect. Dis. 48:S260 -S270.
34. Van Hal SJ, Mathur G, Kelly J, Aronis C, Cranney GB, Jones PD. 2005. The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. J. Infect. 51:218- 221.
35. Valente AM, Jain R, Scheurer M, Fowler VG, Corey GR, Bengur AR, Sanders S, Li JS. 2005. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115:e15- e19. doi:10.1542/peds.2004-1152.
36. World Health Organization. 2011. Global database on body mass index. http://apps.who.int/bmi/index.jsp.Accessed13November2012.
37. Figueiredo LT, Ruiz-Junior E, Schirmbeck T. 2001. Infective endocarditis (IE) first diagnosed at autopsy: analysis of 31 cases in Ribeirão Preto, Brazil. Rev. Inst. Med. Trop. Sao Paulo. 43:213-216.
38. Røder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT. 1999. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch. Intern. Med. 159:462- 469.
39. Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW. 2009. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin. Infect. Dis. 49:395- 401.
40. Park HJ, Kim SH, Kim MJ, Lee YM, Park SY, Moon SM, Park KH, Chong YP, Lee SO, Choi SH, Woo JH, Kim YS. 2012. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J. Infect. 65:505-512.
41. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. 2012. Linezolid in methicillin- resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin. Infect. Dis. 54:621- 629.
42. Crowley AL, Peterson GE, Benjamin DK, Rimmer SH, Todd C, Cabell CH, Reller LB, Ryan T, Corey GR, Fowler VG. 2008. Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit. Care Med. 36:385-390.